NuCana

-$0.46 (-11.83%) Today
$0.00 (0.00%) As of 9:20 AM UTC after-hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, and ETFs commission-free!

About NCNA

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738.

CEO
Hugh Stephen Griffith
Employees
29
Headquarters
Edinburgh, Midlothian
Founded
1997

NCNA Key Statistics

Market Cap
186.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.77K
High Today
$3.90
Low Today
$3.38
Open Price
$3.87
Volume
581.51K
52 Week High
$7.83
52 Week Low
$3.38

NCNA Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 19, After Hours

You May Also Like

NRGX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure